{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T21:19:25Z","timestamp":1794777565561,"version":"4.9.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermer\u00eda Cl\u00ednica (English Edition)"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.enfcle.2026.502533","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:12:01Z","timestamp":1791216721000},"page":"502533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical outcomes associated with the use of the 8% capsaicin patch in localized neuropathic pain: A quasi-experimental study"],"prefix":"10.1016","volume":"36","author":[{"given":"Cristina","family":"Garc\u00eda-Librero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Pab\u00f3n-Carrasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Vilar-Palomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.enfcle.2026.502533_bib0005","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s40265-018-0982-7","article-title":"Capsaicin 8% dermal patch: a review in peripheral neuropathic pain","volume":"78","author":"Blair","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.enfcle.2026.502533_bib0010","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.pain.2011.06.017","article-title":"A new definition of neuropathic pain","volume":"152","author":"Jensen","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.enfcle.2026.502533_bib0015","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1080\/14656566.2020.1759550","article-title":"Capsaicin 8% dermal patch in clinical practice: an expert opinion","volume":"21","author":"Bonezzi","year":"2020","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.enfcle.2026.502533_bib0020","doi-asserted-by":"crossref","first-page":"926","DOI":"10.12968\/bjon.2011.20.15.926","article-title":"The capsaicin 8% patch for peripheral neuropathic pain","volume":"20","author":"England","year":"2011","journal-title":"Br J Nurs"},{"key":"10.1016\/j.enfcle.2026.502533_bib0025","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2147\/JPR.S45743","article-title":"Is physician supervision of the capsaicin 8% patch administration procedure really necessary? An opinion from health care professionals","volume":"6","author":"Kern","year":"2013","journal-title":"J Pain Res"},{"key":"10.1016\/j.enfcle.2026.502533_bib0030","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1212\/CON.0000000000000462","article-title":"Neuropathic pain","volume":"23","author":"Zilliox","year":"2017","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.enfcle.2026.502533_bib0035","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12883-017-0836-z","article-title":"Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: The ASCEND study","volume":"17","author":"Mankowski","year":"2017","journal-title":"BMC Neurol"},{"key":"10.1016\/j.enfcle.2026.502533_bib0040","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3344\/kjp.2018.31.4.253","article-title":"Therapeutic alternatives in painful diabetic neuropathy: a meta-analysis of randomized controlled trials","volume":"31","author":"Vilar","year":"2018","journal-title":"Korean J Pain"},{"key":"10.1016\/j.enfcle.2026.502533_bib0045","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.neurol.2021.07.011","article-title":"Interest of registries in neuropathic pain research","volume":"177","author":"Moisset","year":"2021","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.enfcle.2026.502533_bib0050","article-title":"Topical clonidine for neuropathic pain in adults","volume":"2022","author":"Serednicki","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.enfcle.2026.502533_bib0055","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neurol.2018.08.005","article-title":"Pharmacological treatments of neuropathic pain: the latest recommendations","volume":"175","author":"Attal","year":"2019","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.enfcle.2026.502533_bib0060","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.enfcle.2026.502533_bib0065","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.neurol.2021.07.004","article-title":"French guidelines for neuropathic pain: an update and commentary","volume":"177","author":"Moisset","year":"2021","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.enfcle.2026.502533_bib0070","series-title":"Neuropathic pain in adults: pharmacological management in non-specialist settings","year":"2013"},{"key":"10.1016\/j.enfcle.2026.502533_bib0075","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.3390\/jcm10163533","article-title":"Combination therapy for neuropathic pain: a review of recent evidence","volume":"10","author":"Afonso","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.enfcle.2026.502533_bib0080","article-title":"Managing chronic neuropathic pain: recent advances and new challenges","volume":"2022","author":"Hange","year":"2022","journal-title":"Neurol Res Int"},{"key":"10.1016\/j.enfcle.2026.502533_bib0085","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s40265-015-0520-9","article-title":"Capsaicin 8% patch: a review in peripheral neuropathic pain","volume":"76","author":"Burness","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.enfcle.2026.502533_bib0090","doi-asserted-by":"crossref","first-page":"960","DOI":"10.3390\/jpm11100960","article-title":"Capsaicin 8% patch and chronic postsurgical neuropathic pain","volume":"11","author":"Giaccari","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/j.enfcle.2026.502533_bib0095","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.pmn.2021.12.005","article-title":"Capsaicin 8% dermal patch for neuropathic pain in a pain unit","volume":"23","author":"Aus\u00edn-Crespo","year":"2022","journal-title":"Pain Manag Nurs"},{"key":"10.1016\/j.enfcle.2026.502533_bib0100","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0304-3959(81)90199-8","article-title":"Measurement of pain: patient preference does not confound pain measurement","volume":"10","author":"Kremer","year":"1981","journal-title":"Pain"},{"key":"10.1016\/j.enfcle.2026.502533_bib0105","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0210-5691(06)74552-1","article-title":"Monitorizaci\u00f3n del dolor: Recomendaciones del grupo de trabajo de analgesia y sedaci\u00f3n de la SEMICYUC","volume":"30","author":"Pardo","year":"2006","journal-title":"Med Intensiva"},{"key":"10.1016\/j.enfcle.2026.502533_bib0110","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1365-2702.2005.01121.x","article-title":"Pain: a review of three commonly used pain rating scales","volume":"14","author":"Williamson","year":"2005","journal-title":"J Clin Nurs"},{"key":"10.1016\/j.enfcle.2026.502533_bib0115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol \u2014 a new facility for the measurement of health-related quality of life","volume":"16","year":"1990","journal-title":"Health Policy"},{"key":"10.1016\/j.enfcle.2026.502533_bib0120","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1007\/s11136-018-1877-5","article-title":"Validity of the EQ-5D-5L and reference norms for the Spanish population","volume":"27","author":"Hernandez","year":"2018","journal-title":"Qual Life Res"},{"key":"10.1016\/j.enfcle.2026.502533_bib0125","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.sleep.2008.06.003","article-title":"Psychometric evaluation and tests of validity of the Medical Outcomes Study 12-item Sleep Scale (MOS sleep)","volume":"10","author":"Allen","year":"2009","journal-title":"Sleep Med"},{"key":"10.1016\/j.enfcle.2026.502533_bib0130","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s41687-021-00311-3","article-title":"The development and validation of a revised version of the Medical Outcomes Study Sleep Scale (MOS Sleep-R)","volume":"5","author":"Yarlas","year":"2021","journal-title":"J Patient Rep Outcomes"},{"key":"10.1016\/j.enfcle.2026.502533_bib0135","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jpain.2009.06.007","article-title":"The clinical importance of changes in the 0 to 10 numeric rating scale for worst, least, and average pain intensity: analyses of data from clinical trials of duloxetine in pain disorders","volume":"11","author":"Farrar","year":"2010","journal-title":"J Pain"},{"key":"10.1016\/j.enfcle.2026.502533_bib0140","doi-asserted-by":"crossref","first-page":"228","DOI":"10.20986\/resed.2018.3632\/2017","article-title":"Valoraci\u00f3n del dolor. Revisi\u00f3n comparativade escalas y cuestionarios","volume":"25","author":"Vicente-Herrero","year":"2018","journal-title":"Rev Soc Esp Dolor"},{"key":"10.1016\/j.enfcle.2026.502533_bib0145","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"A power primer","volume":"112","author":"Cohen","year":"1992","journal-title":"Psychol Bull"},{"key":"10.1016\/j.enfcle.2026.502533_bib0150","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tjem.2018.08.001","article-title":"User\u2019s guide to correlation coefficients","volume":"18","author":"Akoglu","year":"2018","journal-title":"Turk J Emerg Med"},{"key":"10.1016\/j.enfcle.2026.502533_bib0155","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/ejp.1155","article-title":"Superiority of capsaicin 8% patch versus oral pregabalin on dynamic mechanical allodynia in patients with peripheral neuropathic pain","volume":"22","author":"Cruccu","year":"2018","journal-title":"Eur J Pain"},{"key":"10.1016\/j.enfcle.2026.502533_bib0160","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/AJP.0000000000000473","article-title":"Capsaicin 8% patch repeat treatment in nondiabetic peripheral neuropathic pain: a 52-week, open-label, single-arm, safety study","volume":"33","author":"G\u00e1lvez","year":"2017","journal-title":"Clin J Pain"},{"key":"10.1016\/j.enfcle.2026.502533_bib0165","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/20494637231201502","article-title":"Topical capsaicin 8% patch in peripheral neuropathic pain: efficacy and quality of life","volume":"18","author":"Santos","year":"2024","journal-title":"Br J Pain"},{"key":"10.1016\/j.enfcle.2026.502533_bib0170","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/j.pain.0000000000002735","article-title":"Capsaicin treatment in neuropathic pain: axon reflex vasodilatation after 4 weeks correlates with pain reduction","volume":"164","author":"Sendel","year":"2023","journal-title":"Pain"},{"key":"10.1016\/j.enfcle.2026.502533_bib0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107743","article-title":"Fight fire with fire: neurobiology of capsaicin-induced analgesia for chronic pain","volume":"220","author":"Arora","year":"2021","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.enfcle.2026.502533_bib0180","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11916-020-00886-4","article-title":"Novel agents in neuropathic pain, the role of capsaicin: pharmacology, efficacy, side effects, different preparations","volume":"24","author":"Hall","year":"2020","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.enfcle.2026.502533_bib0185","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3390\/pharmaceutics13040450","article-title":"Topical treatments and their molecular\/cellular mechanisms in patients with peripheral neuropathic pain-narrative review","volume":"13","author":"Kocot-K\u0119pska","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.enfcle.2026.502533_bib0190","first-page":"E641","article-title":"Observational study capsaicin 8% for peripheral neuropathic pain treatment: a retrospective cohort study","volume":"25","author":"Regina","year":"2022","journal-title":"Pain Physician"},{"key":"10.1016\/j.enfcle.2026.502533_bib0195","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1744-1609.2010.00173.x","article-title":"Summaries of nursing care-related systematic reviews from the Cochrane Library: Topical capsaicin for chronic neuropathic pain in adults","volume":"8","author":"Norrie","year":"2010","journal-title":"Int J Evid Based Healthc"},{"key":"10.1016\/j.enfcle.2026.502533_bib0200","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/NUR.0000000000000296","article-title":"Advancing nursing practice: management of neuropathic pain with capsaicin 8% without physician supervision","volume":"31","author":"O\u2019Brien","year":"2017","journal-title":"Clin Nurse Spec"}],"container-title":["Enfermer\u00eda Cl\u00ednica (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2445147926001037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2445147926001037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T21:02:10Z","timestamp":1794776530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2445147926001037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2445147926001037"],"URL":"https:\/\/doi.org\/10.1016\/j.enfcle.2026.502533","relation":{},"ISSN":["2445-1479"],"issn-type":[{"value":"2445-1479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcomes associated with the use of the 8% capsaicin patch in localized neuropathic pain: A quasi-experimental study","name":"articletitle","label":"Article Title"},{"value":"Enfermer\u00eda Cl\u00ednica (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.enfcle.2026.502533","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.enfcli.2026.502533","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"502533"}}